Machine Learning

A $15M grant fuels a revolutionary therapy for a fatal childhood disease, turning patients' own cells into 'living biofactories' to fight MPS I.

After promising results in a key patient subgroup, the PREVAiLS study will test if pridopidine can slow the relentless progression of ALS.

Following rapid growth and a private equity acquisition, DAS Health appoints Lee Horner to navigate healthcare's complex digital and cybersecurity challenges.

Neumora reveals promising data for Alzheimer's and schizophrenia drugs, but a delay in its obesity program highlights the high-stakes world of biotech.

Magnachip's new power semiconductors promise major efficiency and density gains for servers, tackling the soaring energy needs of the growing AI boom.

An Australian startup's new AI trading platform promises to master crypto volatility, but it enters a crowded market facing security and regulatory hurdles.

China's literary giant Yuewen leverages AI and a new generation of creators to build a global IP empire, from novels to AI-dramas and merchandise.

FoodTrack is ditching calorie counting, blending AI with Traditional Chinese wellness to offer personalized health insights from photos of your meals, face, and tongue.

Equasens reports a 9.1% revenue jump, driven by AI investment and key acquisitions, as the company navigates a major leadership change and market shifts.

Transform 2026 saw the launch of a national AI literacy plan and a new model for leadership, proving the future of work is about people, not just code.

Chery's iCAUR will unveil its 'new energy system' at Auto China 2026. The summit showcases a holistic vision beyond powertrains with new V23 and V27 SUVs.

A Denver clinic now offers Therapeutic Plasma Exchange for anti-aging. But does the science back up the high-cost promise of turning back the clock?

IT services leader NexusTek is bringing advanced AI to growers, aiming to solve data fragmentation and boost efficiency in a booming agri-tech market.

A landmark partnership is scaling a 'one-drug, many-diseases' therapy, revealing how logistics, not just labs, are key to the future of medicine.

Navigator Medicines pushes two novel bispecific antibodies for Hidradenitis Suppurativa, promising better efficacy and patient-friendly dosing.

A $520K state grant will provide firefighters with a new AI-powered blood test, highlighting a major push to protect high-risk first responders.

New 3-year trial data shows UCB's BIMZELX prevents painful flares in most HS patients, highlighting a critical window for early intervention.

Indian tech firm Lexlegis launches its Legal AID platform in the U.S., promising a new 'Legal Intelligence Factory' free from AI errors.

Independent firm FPA is nominated for a top Morningstar award alongside PIMCO and Vanguard, highlighting its rare focus on investor returns over asset size.

FDA greenlights a novel, AI-discovered therapy for a Phase 1 trial, offering new hope for children with devastating central nervous system tumors.